HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Leucovorin
Related studies linked through entity extraction aliases.
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
- Status
- COMPLETED
- Phase
- PHASE1
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- Status
- RECRUITING
- Phase
- PHASE1
Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2